Urology

Latest Ask the Experts

Biomarker Assays for Prostate Cancer Management

Should biomarker assays be an integral part of prostate cancer patient care?

Urology News

Latest Urology News

Kidney Cancer Geriatric Consultation Uncommon in Kidney Cancer Surgery

Geriatric Consultation Uncommon in Kidney Cancer Surgery

Participant age and comorbidity burden appeared to be consistent determinants of use of services, although hospital-level variation was also noted.

Prostate Cancer Urologist Ownership of IMRT Linked to Its Greater Use for PCa

Urologist Ownership of IMRT Linked to Its Greater Use for PCa

Patients are more likely to receive intensity-modulated radiation therapy if they are managed by urology practices with an ownership interest in the modality, study finds.

Urology Cancer Trial Participation Up Under ACA

Cancer Trial Participation Up Under ACA

There were no significant changes in insurer approval rates or referral wait times for patients covered by Medicare or Medicaid.

Bladder Cancer Researchers: Iron-based Binders Best for Hyperphosphatemia

Researchers: Iron-based Binders Best for Hyperphosphatemia

Of 7 phosphate binders, iron-based agents were optimal when efficacy and safety are considered.

Bladder Cancer CKD May Be a Risk Factor for NMIBC Recurrence, Progression

CKD May Be a Risk Factor for NMIBC Recurrence, Progression

Stage G3b-5 chronic kidney disease independently predicted a nearly 2-fold increased risk recurrence and 3-fold increased risk of progression following transurethral resection.

Bladder Cancer Short-term Arterial Thromboembolism Risk Elevated in Cancer Patients

Short-term Arterial Thromboembolism Risk Elevated in Cancer Patients

The six-month cumulative incidence of myocardial infarction was 2.0% and 0.7% in patients with cancer and controls, respectively.

Bladder Cancer Bladder Preservation Therapy Linked With Reduced Survival in MIBC

Bladder Preservation Therapy Linked With Reduced Survival in MIBC

Radical cystectomy is associated with better survival, but findings suggest BPT may produce acceptable oncologic outcomes in appropriately selected patients.

Bladder Cancer Immediate Post-TURBT Mitomycin C Reduces NMIBC Recurrence Risk

Immediate Post-TURBT Mitomycin C Reduces NMIBC Recurrence Risk

Instilling mitomycin C within 24 hours of TURBT vs after 2 weeks was associated with a 27% lower risk of recurrence.

Bladder Cancer Study: Cystectomy Complication Rate Not Improving

Study: Cystectomy Complication Rate Not Improving

Researchers find no significant change in overall complication rate from 2010 to 2015, but hospital length of stay and need for transfusion have declined.

Kidney Cancer Targeted Multigene Panel Testing Useful for Hereditary Kidney Cancer

Targeted Multigene Panel Testing Useful for Hereditary Kidney Cancer

The most commonly altered genes were folliculin and fumarate hydratase in 1.8% and 1.3%, respectively.

Prostate Cancer Cancer Patient Self-Reporting Reliable and Feasible, Studies Show

Cancer Patient Self-Reporting Reliable and Feasible, Studies Show

Prostate cancer patients accurately report their comorbidities, and participants in cancer clinical trials report more adverse events than trial investigators.

Prostate Cancer Osteoporosis Drugs Up Bone Mineral Density in Nonmetastatic PCa

Osteoporosis Drugs Up Bone Mineral Density in Nonmetastatic PCa

Improvement in BMD was seen with denosumab, which also reduced the incidence of new radiographic vertebral fractures in one high-quality trial.

Prostate Cancer Not All High-Risk Prostate Cancers Are the Same

Not All High-Risk Prostate Cancers Are the Same

Men with 1 high-risk factor experience better outcomes following treatment than those with 2 or 3 high-risk factors, study finds.

Prostate Cancer Blacks Less Likely to Undergo Definitive Prostate Cancer Therapy

Blacks Less Likely to Undergo Definitive Prostate Cancer Therapy

Study of men with intermediate- or high-risk prostate cancer finds facility-level racial disparity in use of definitive treatment.

Urology Some Elders With Rectal Cancer Don't Receive Tx

Some Elders With Rectal Cancer Don't Receive Tx

Worse overall survival was seen in association with male sex, older age, worsening comorbidities, and receiving no treatment or undergoing surgery alone.

Hypogonadism FDA Clears Betrixaban For VTE Prophylaxis

FDA Clears Betrixaban For VTE Prophylaxis

Fewer VTE events were observed in the betrixaban than enoxaparin arm.

Prostate Cancer Timing of PSA Nadir Post-RP Predicts Biochemical Recurrence Risk

Timing of PSA Nadir Post-RP Predicts Biochemical Recurrence Risk

A detectable PSA nadir combined with shorter time to nadir after prostate cancer surgery is associated with a higher risk of biochemical recurrence.

Prostate Cancer Positive Lymph Node Prostate Cancer Care Patterns Characterized

Positive Lymph Node Prostate Cancer Care Patterns Characterized

63% of patients were managed initially with observation.

Urology Opioids Still Overprescribed

Opioids Still Overprescribed

Nearly 92 million Americans used legitimately prescribed opioids in 2015, survey shows

Prostate Cancer Active Surveillance for Intermediate-Risk PCa May Be Unsafe

Active Surveillance for Intermediate-Risk PCa May Be Unsafe

Nearly 1 in 3 patients diagnosed with Gleason 3+4 favorable intermediate-risk prostate cancer had their disease upgraded or upstaged at radical prostatectomy.